{"Title": ["Concert Pharmaceuticals, Inc. (CNCE) Q1 2020 Earnings Call Transcript", "Concert Pharmaceuticals, Inc. (CNCE) Q4 2019 Earnings Call Transcript", "CNCE Hits Right Notes, BXRX Faces FDA In Feb., All Eyes On AGTC", "Concert Pharmaceuticals, Inc. (CNCE) Q3 2019 Earnings Call Transcript", "Friday 10/11 Insider Buying Report: CNCE, SOR", "Why Concert Pharmaceuticals Stock Is Tanking Today", "Concert Pharmaceuticals, Inc. (CNCE) Q2 2019 Earnings Call Transcript", "Concert Pharmaceuticals, Inc. (CNCE) Q1 2019 Earnings Call Transcript", "Concert Pharmaceuticals, Inc. (CNCE) Q1 2020 Earnings Call Transcript", "New Strong Sell Stocks for March 25th", "Noteworthy Thursday Option Activity: FRO, AMTD, CNCE", "New Strong Sell Stocks for March 12th", "Vertex's VX-445 Triple Combo Cystic Fibrosis Trials Succeed", "Concert Pharmaceuticals, Inc. (CNCE) Q4 2018 Earnings Conference Call Transcript", "The 9 Best Biotech Stocks to Buy for a Blowout 2019", "Friday 11/16 Insider Buying Report: WYNN, CNCE", "CNCE Hits A Low, UTHR Throws In The Towel On PAH Drug, ZGNX Plunges On FDA Snub", "Validea's Top Five Healthcare Stocks Based On David Dreman - 7/15/2018", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 7/15/2018", "Validea's Top Five Healthcare Stocks Based On David Dreman - 6/17/2018", "Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 3/18/2018", "Validea's Top Five Healthcare Stocks Based On David Dreman - 2/18/2018", "Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 2/18/2018", "Vertex's Third Cystic Fibrosis Treatment Gets FDA Approval", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 8/19/2018", "Vertex (VRTX) Stock Up 70% in a Year's Time: Here's Why", "Stocks Showing Market Leadership: Concert Pharmaceuticals Earns 93 RS Rating", "Concert Pharmaceuticals Plunges on Patent Petition Setback", "Health Care Sector Update for 01/12/2018: JNJ, PFE, ABT, MRK, AMGN, CNCE, INCY, GSK, PSTI, VRX", "Health Care Sector Update for 01/12/2018: VRX,VRX.TO,PSTI,GSK,CNCE,INCY", "Why Concert Pharmaceuticals, Inc. Is Singing the Blues Today", "Health Care Sector Update for 01/12/2018: PSTI,GSK,CNCE,INCY", "Vertex (VRTX) Q4 Earnings Beat on Strong CF Products Sales", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 11/16/2017", "Vertex Gets CHMP Recommendation for Orkambi Label Expansion", "Why General Electric, Concert Pharmaceuticals, and NVR Jumped Today", "3 Monster Biotech Stocks in the Making", "Zacks.com featured highlights: AppFolio, Columbus McKinnon, Concert Pharmaceuticals, Aceto and Liberty Media", "5 Stocks to Bet on New Analyst Coverage", "Vertex Pharmaceuticals Incorporated Chugs Along", "Concert Pharmaceuticals (CNCE) Soars: Stock Adds 5.7% in Session", "Here's Why Investors Are Glued to Vertex Pharma (VRTX) Stock", "Notable Tuesday Option Activity: WDAY, CNCE, ULTA", "Concert Pharma Falls After Clinical Hold on Hair Loss Drug", "Health Care Sector Update for 05/17/2017: GTHX,SNDX,CNCE", "Health Care Sector Update for 05/17/2017: OMER,SNDX,CNCE", "Why Is Vertex Pharma (VRTX) Stock Soaring This Year?", "Vertex Pharmaceuticals Incorporated: Solid Sales, Prepping for Next Generation", "Vertex (VRTX) Q2 Earnings Top on Solid Cystic Fibrosis Sales", "Will Concert Pharmaceuticals (CNCE) Continue to Surge Higher?", "Moving Average Crossover Alert: Concert Pharmaceuticals (CNCE)", "After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead", "3 Biotech Stocks to Buy in March", "Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M", "Why Concert Pharmaceuticals Stock Is Soaring Today", "Pre-Market Most Active for Mar 6, 2017 : SNAP, DB, BAC, TVIX, GM, CS, UN, MU, AUPH, GPRO, PTCT, CNCE", "Vertex (VRTX) Q1 Earnings Top, CF Products Sales Strong", "Health Care Sector Update for 03/06/2017: CNCE,VTRX,TGTX,IONS", "Midday Update: Risk Aversion Prevails as N. Korea Fires Missiles, China Lowers Growth, Juppe Rules Out French Run", "Pre-Market Earnings Report for March 6, 2017 : FRP, MEET, CNCE, MVIS", "Concert's (CNCE) CTP-656 Gets Orphan Drug Status in U.S.", "Concert Offers Update on Cystic Fibrosis Drug, Stock Down", "Tuesday Sector Laggards: Drugs, Biotechnology Stocks", "Will Concert Pharmaceuticals (CNCE) Continue to Surge Higher?", "Close Update: Wall Street Pares Losses But Weaker Finish Eyed as Politics, Rate Hike Weigh", "Concert's Early-Stage Cystic Fibrosis Drug Shows Promise", "Increased Earnings Estimates Seen for Concert Pharmaceuticals (CNCE): Can It Move Higher?", "Concert Pharmaceuticals (CNCE): Strong Industry, Solid Earnings Estimate Revisions", "Instant Analysis: Vertex Pharmaceuticals Grabs an Important Regulatory Win", "Jazz's Q3 Earnings & Revenues Grow Y/Y; Trims 2015 Outlook", "Vertex Turns Up the Heat on Cystic Fibrosis Challengers", "A Double-Dose of Bad News Rocks Vertex Pharmaceuticals in September", "Concert Pharmaceuticals (CNCE) in Focus: Stock Rises 5.6%", "Concert's Early-Stage Cystic Fibrosis Drug Shows Promise", "Increased Earnings Estimates Seen for Concert Pharmaceuticals (CNCE): Can It Move Higher?", "Concert Pharmaceuticals (CNCE) in Focus: Stock Rises 5.2% - Tale of the Tape", "Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up", "Concert Pharmaceuticals (CNCE) Crumbles: Stock Falls by 5.4% - Tale of the Tape", "Why Shares of Flamel Technologies SA Bolted Higher Today", "Concert Pharmaceuticals (CNCE) Jumps: Stock Rises 23.1%", "Concert Pharmaceuticals (CNCE) in Focus: Stock Tumbles 10.8% - Tale of the Tape", "Why Concert Pharmaceuticals Inc. Shares Were Hammered", "Concert Pharmaceuticals (CNCE) Jumps: Stock Rises 6.7% - Tale of the Tape", "Concert Pharmaceuticals (CNCE) Jumps: Stock Rises 8.5% - Tale of the Tape", "JAZZ Pharmaceuticals Slips After Dosing Issue on JZP-386 - Analyst Blog", "Concert Pharmaceuticals Announces Positive CTP-354 Data - Analyst Blog", "Kidney failure biotech Proteon Therapeutics sets terms for $61 million IPO", "Jazz Pharmaceuticals Misses on Q1 Earnings, Affirms View - Analyst Blog", "Concert Pharmaceuticals (CNCE) in Focus: Stock Tumbles 10.8% - Tale of the Tape", "Why Concert Pharmaceuticals Inc. Shares Were Hammered", "Why Concert Pharmaceuticals (CNCE) Could Shock the Market Soon - Tale of the Tape", "Concert Pharmaceuticals (CNCE) Catches Eye: Stock Up 9.3% - Tale of the Tape", "US IPO Recap: Wave goodbye to the biotech wave as tech prepares to take over", "Concert Pharmaceuticals prices upsized IPO at $14, the high end of the range", "Concert Pharmaceuticals (CNCE) Soars: Stock Rises 25.8% - Tale of the Tape", "Biotech Concert Pharmaceuticals sets terms for $75 million IPO", "US IPO Recap: Wave goodbye to the biotech wave as tech prepares to takes over", "9 US IPOs planned for the week of Feb 10"], "Elapsed Time": ["MAY 1, 2020", "FEB 27, 2020", "JAN 22, 2020", "NOV 9, 2019", "OCT 11, 2019", "SEP 27, 2019", "AUG 6, 2019", "MAY 2, 2019", "MAY 1, 2020", "MAR 25, 2019", "MAR 21, 2019", "MAR 12, 2019", "MAR 7, 2019", "FEB 28, 2019", "FEB 5, 2019", "NOV 16, 2018", "APR 8, 2019", "JUL 15, 2018", "JUL 15, 2018", "JUN 17, 2018", "MAR 18, 2018", "FEB 18, 2018", "FEB 18, 2018", "FEB 13, 2018", "AUG 19, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 15, 2018", "JAN 12, 2018", "JAN 12, 2018", "JAN 12, 2018", "JAN 12, 2018", "FEB 1, 2018", "NOV 16, 2017", "NOV 13, 2017", "OCT 19, 2017", "SEP 24, 2017", "AUG 22, 2017", "AUG 21, 2017", "JUL 28, 2017", "DEC 4, 2017", "JUN 23, 2017", "MAY 30, 2017", "MAY 18, 2017", "MAY 17, 2017", "MAY 17, 2017", "MAY 16, 2017", "MAY 1, 2017", "JUL 27, 2017", "MAR 24, 2017", "MAR 17, 2017", "MAR 15, 2017", "MAR 10, 2017", "MAR 7, 2017", "MAR 6, 2017", "MAR 6, 2017", "APR 28, 2017", "MAR 6, 2017", "MAR 6, 2017", "MAR 3, 2017", "JAN 23, 2017", "JAN 18, 2017", "JAN 17, 2017", "DEC 29, 2016", "MAR 6, 2017", "MAR 1, 2016", "DEC 8, 2015", "DEC 1, 2015", "NOV 20, 2015", "NOV 11, 2015", "OCT 19, 2015", "OCT 2, 2015", "APR 25, 2016", "MAR 1, 2016", "DEC 8, 2015", "AUG 6, 2015", "JUL 28, 2015", "JUN 29, 2015", "MAY 8, 2015", "SEP 24, 2015", "MAR 20, 2015", "MAR 19, 2015", "MAR 12, 2015", "FEB 20, 2015", "DEC 10, 2014", "OCT 15, 2014", "OCT 7, 2014", "MAY 8, 2015", "MAR 20, 2015", "MAR 19, 2015", "MAY 13, 2014", "APR 1, 2014", "FEB 18, 2014", "FEB 13, 2014", "SEP 16, 2014", "FEB 3, 2014", "JUL 12, 2013", "FEB 10, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/concert-pharmaceuticals-inc.-cnce-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/concert-pharmaceuticals-inc.-cnce-q4-2019-earnings-call-transcript-2020-02-28", "https://www.nasdaq.com/articles/cnce-hits-right-notes-bxrx-faces-fda-in-feb.-all-eyes-on-agtc-2020-01-22", "https://www.nasdaq.com/articles/concert-pharmaceuticals-inc.-cnce-q3-2019-earnings-call-transcript-2019-11-09", "https://www.nasdaq.com/articles/friday-10-11-insider-buying-report%3A-cnce-sor-2019-10-11", "https://www.nasdaq.com/articles/why-concert-pharmaceuticals-stock-is-tanking-today-2019-09-27", "https://www.nasdaq.com/articles/concert-pharmaceuticals-inc.-cnce-q2-2019-earnings-call-transcript-2019-08-06", "https://www.nasdaq.com/articles/concert-pharmaceuticals-inc.-cnce-q1-2019-earnings-call-transcript-2019-05-02", "https://www.nasdaq.com/articles/concert-pharmaceuticals-inc.-cnce-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-25th-2019-03-25", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-fro-amtd-cnce-2019-03-21", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-12th-2019-03-12", "https://www.nasdaq.com/articles/vertexs-vx-445-triple-combo-cystic-fibrosis-trials-succeed-2019-03-07", "https://www.nasdaq.com/articles/concert-pharmaceuticals-inc-cnce-q4-2018-earnings-conference-call-transcript-2019-02-28", "https://www.nasdaq.com/articles/9-best-biotech-stocks-buy-blowout-2019-2019-02-05", "https://www.nasdaq.com/articles/friday-1116-insider-buying-report-wynn-cnce-2018-11-16", "https://www.nasdaq.com/articles/cnce-hits-low-uthr-throws-towel-pah-drug-zgnx-plunges-fda-snub-2019-04-09", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-david-dreman-7152018-2018-07-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-kenneth-fisher-7152018-2018-07-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-david-dreman-6172018-2018-06-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-joel-greenblatt-3182018-2018-03-18", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-david-dreman-2182018-2018-02-18", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-joel-greenblatt-2182018-2018-02-18", "https://www.nasdaq.com/articles/vertexs-third-cystic-fibrosis-treatment-gets-fda-approval-2018-02-13", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-kenneth-fisher-8192018-2018-08-19", "https://www.nasdaq.com/articles/vertex-vrtx-stock-up-70-in-a-years-time%3A-heres-why-2018-01-25", "https://www.nasdaq.com/articles/stocks-showing-market-leadership-concert-pharmaceuticals-earns-93-rs-rating-2018-01-25", "https://www.nasdaq.com/articles/concert-pharmaceuticals-plunges-on-patent-petition-setback-2018-01-15", "https://www.nasdaq.com/articles/health-care-sector-update-01122018-jnj-pfe-abt-mrk-amgn-cnce-incy-gsk-psti-vrx-2018-01-12", "https://www.nasdaq.com/articles/health-care-sector-update-01122018-vrxvrxtopstigskcnceincy-2018-01-12", "https://www.nasdaq.com/articles/why-concert-pharmaceuticals-inc-singing-blues-today-2018-01-12", "https://www.nasdaq.com/articles/health-care-sector-update-01122018-pstigskcnceincy-2018-01-12", "https://www.nasdaq.com/articles/vertex-vrtx-q4-earnings-beat-on-strong-cf-products-sales-2018-02-01", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-11162017-2017-11-16", "https://www.nasdaq.com/articles/vertex-gets-chmp-recommendation-for-orkambi-label-expansion-2017-11-13", "https://www.nasdaq.com/articles/why-general-electric-concert-pharmaceuticals-and-nvr-jumped-today-2017-10-19", "https://www.nasdaq.com/articles/3-monster-biotech-stocks-making-2017-09-24", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-appfolio-columbus-mckinnon-concert-pharmaceuticals-aceto", "https://www.nasdaq.com/articles/5-stocks-to-bet-on-new-analyst-coverage-2017-08-21", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-chugs-along-2017-07-28", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-soars%3A-stock-adds-5.7-in-session-2017-12-04", "https://www.nasdaq.com/articles/heres-why-investors-are-glued-to-vertex-pharma-vrtx-stock-2017-06-23", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-wday-cnce-ulta-2017-05-30", "https://www.nasdaq.com/articles/concert-pharma-falls-after-clinical-hold-on-hair-loss-drug-2017-05-18", "https://www.nasdaq.com/articles/health-care-sector-update-05172017-gthxsndxcnce-2017-05-17", "https://www.nasdaq.com/articles/health-care-sector-update-05172017-omersndxcnce-2017-05-17", "https://www.nasdaq.com/articles/why-is-vertex-pharma-vrtx-stock-soaring-this-year-2017-05-16", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-incorporated-solid-sales-prepping-next-generation-2017-05-01", "https://www.nasdaq.com/articles/vertex-vrtx-q2-earnings-top-on-solid-cystic-fibrosis-sales-2017-07-27", "https://www.nasdaq.com/articles/will-concert-pharmaceuticals-cnce-continue-to-surge-higher-2017-03-24", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-concert-pharmaceuticals-cnce-2017-03-17", "https://www.nasdaq.com/articles/after-valeant-here-are-5-drug-stocks-bill-ackman-should-buy-instead-2017-03-15", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-march-2017-03-10", "https://www.nasdaq.com/articles/vertex-to-buy-concerts-cystic-fibrosis-candidate-for-%24160m-2017-03-07", "https://www.nasdaq.com/articles/why-concert-pharmaceuticals-stock-soaring-today-2017-03-06", "https://www.nasdaq.com/articles/pre-market-most-active-mar-6-2017-snap-db-bac-tvix-gm-cs-un-mu-auph-gpro-ptct-cnce-2017-03", "https://www.nasdaq.com/articles/vertex-vrtx-q1-earnings-top-cf-products-sales-strong-2017-04-28", "https://www.nasdaq.com/articles/health-care-sector-update-03062017-cncevtrxtgtxions-2017-03-06", "https://www.nasdaq.com/articles/midday-update-risk-aversion-prevails-n-korea-fires-missiles-china-lowers-growth-juppe", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-6-2017-frp-meet-cnce-mvis-2017-03-03", "https://www.nasdaq.com/articles/concerts-cnce-ctp-656-gets-orphan-drug-status-in-u.s.-2017-01-23", "https://www.nasdaq.com/articles/concert-offers-update-on-cystic-fibrosis-drug-stock-down-2017-01-18", "https://www.nasdaq.com/articles/tuesday-sector-laggards-drugs-biotechnology-stocks-2017-01-17", "https://www.nasdaq.com/articles/will-concert-pharmaceuticals-cnce-continue-to-surge-higher-2016-12-29", "https://www.nasdaq.com/articles/close-update-wall-street-pares-losses-weaker-finish-eyed-politics-rate-hike-weigh-2017-03", "https://www.nasdaq.com/articles/concerts-early-stage-cystic-fibrosis-drug-shows-promise-2016-03-01", "https://www.nasdaq.com/articles/increased-earnings-estimates-seen-for-concert-pharmaceuticals-cnce%3A-can-it-move-higher", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce%3A-strong-industry-solid-earnings-estimate-revisions-2015-12-01", "https://www.nasdaq.com/articles/instant-analysis-vertex-pharmaceuticals-grabs-important-regulatory-win-2015-11-20", "https://www.nasdaq.com/articles/jazzs-q3-earnings-revenues-grow-y-y-trims-2015-outlook-2015-11-11", "https://www.nasdaq.com/articles/vertex-turns-heat-cystic-fibrosis-challengers-2015-10-19", "https://www.nasdaq.com/articles/double-dose-bad-news-rocks-vertex-pharmaceuticals-september-2015-10-02", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-in-focus%3A-stock-rises-5.6-2016-04-25", "https://www.nasdaq.com/articles/concerts-early-stage-cystic-fibrosis-drug-shows-promise-2016-03-01", "https://www.nasdaq.com/articles/increased-earnings-estimates-seen-for-concert-pharmaceuticals-cnce%3A-can-it-move-higher", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-in-focus%3A-stock-rises-5.2-tale-of-the-tape-2015-08-06", "https://www.nasdaq.com/articles/wakefulness-drug-xyrem-keeps-jazz-pharmaceuticals-2015-07-28", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-crumbles%3A-stock-falls-by-5.4-tale-of-the-tape-2015-06-29", "https://www.nasdaq.com/articles/why-shares-flamel-technologies-sa-bolted-higher-today-2015-05-08", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-jumps%3A-stock-rises-23.1-2015-09-24", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-in-focus%3A-stock-tumbles-10.8-tale-of-the-tape-2015-03-20", "https://www.nasdaq.com/articles/why-concert-pharmaceuticals-inc-shares-were-hammered-2015-03-19", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-jumps%3A-stock-rises-6.7-tale-of-the-tape-2015-03-12", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-jumps%3A-stock-rises-8.5-tale-of-the-tape-2015-02-20", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-slips-after-dosing-issue-on-jzp-386-analyst-blog-2014-12-10", "https://www.nasdaq.com/articles/concert-pharmaceuticals-announces-positive-ctp-354-data-analyst-blog-2014-10-15", "https://www.nasdaq.com/articles/kidney-failure-biotech-proteon-therapeutics-sets-terms-61-million-ipo-2014-10-07", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-misses-on-q1-earnings-affirms-view-analyst-blog-2015-05-08", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-in-focus%3A-stock-tumbles-10.8-tale-of-the-tape-2015-03-20", "https://www.nasdaq.com/articles/why-concert-pharmaceuticals-inc-shares-were-hammered-2015-03-19", "https://www.nasdaq.com/articles/why-concert-pharmaceuticals-cnce-could-shock-the-market-soon-tale-of-the-tape-2014-05-13", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-catches-eye%3A-stock-up-9.3-tale-of-the-tape-2014-04-01", "https://www.nasdaq.com/articles/us-ipo-recap-wave-goodbye-biotech-wave-tech-prepares-take-over-2014-02-18", "https://www.nasdaq.com/articles/concert-pharmaceuticals-prices-upsized-ipo-14-high-end-range-2014-02-13", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-soars%3A-stock-rises-25.8-tale-of-the-tape-2014-09-16", "https://www.nasdaq.com/articles/biotech-concert-pharmaceuticals-sets-terms-75-million-ipo-2014-02-03", "https://www.nasdaq.com/articles/us-ipo-recap-wave-goodbye-biotech-wave-tech-prepares-takes-over-2013-07-12", "https://www.nasdaq.com/articles/9-us-ipos-planned-week-feb-10-2014-02-10"], "Content": []}